OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

GNPX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Genprex (GNPX) Earnings Date & Reports

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

GNPX is expected to report earnings to rise 1,053.85% to -300 cents per share on March 29

Q4'23

Est.

$-3.00

Q1'25

Beat

by $0.60

Q4'24

Missed

by $0.39

Q3'23

Missed

by $4.50

Q2'23

Missed

by $5.07

The last earnings report on May 12 showed earnings per share of -25 cents, beating the estimate of -86 cents. With 136.41K shares outstanding, the current market capitalization sits at 7.54M.

View a ticker or compare two or three

Compare

GNPX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GNPX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of molecular therapies for cancer treatment

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

3300 Bee Cave Road

Phone

+1 877 774-4679

Employees

Web

https://www.genprex.com